INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00770a

Intravenous ultrasound-guided balloon pulmonary angioplasty in the treatment of totally occluded chronic thromboembolic pulmonary hypertension

Shinya Nagayoshi*, MD; Shinya Fujii, MD; Takatomo Nakajima, MD, PhD; Makoto Muto, MD, PhD

Balloon pulmonary angioplasty (BPA) is efficacious in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH)1,2. Lesions of CTEPH are categorised by their characteristic appearance on pulmonary angiography3. While there are studies using intravascular ultrasound (IVUS)-guided BPA for inoperable CTEPH1, there are currently no established procedures specifically for chronic totally occluded (CTO) lesions.

The patient was a 66-year-old female. Pulmonary artery angiography with a Profit 6 Fr JL4 guide catheter (Goodman, Aichi, Japan), anteroposterior straight view, showed CTO of the left inferior lingual artery (Panel A). A 190 cm guidewire (Chevalier® 14 tapered 30; Cordis, Cardinal Health, Tokyo, Japan) was advanced slightly into the organised thrombus while guiding with IVUS using an Eagle Eye® Platinum ST catheter (Philips, Amsterdam, the Netherlands) along the guidewire. We confirmed the location of the IVUS catheter within the organised thrombus (Panel B2, image of position on Panel B1) and continued to advance it while maintaining the position of the guidewire (Moving image 1, Moving image 2).

When the location of the IVUS catheter in the true lumen of the vessel was confirmed, it was further advanced through the CTO into the distal true lumen (Panel B3, image of position on Panel B1). The lesion was then dilated with a 4 mm balloon catheter. With the preceding technique using IVUS, we could complete the BPA of the CTO (Panel C). No side effects were noted with this procedure.

The spherical tip of the IVUS catheter and the imaging distance of the tip of only 2.5 mm allowed the identification and advancement of the IVUS catheter through the true vessel. The risk of perforating the pulmonary artery is low using this technique. We could also reach the true lumen using this procedure despite poor peripheral blood flow immediately after the BPA. However, since the thickness of the layer of organised thrombus is unique to each lesion, the IVUS catheter may not pass through some lesions where the thrombus is too thick. The rigidity of the Eagle Eye catheter might also preclude its use in severely tortuous vessels, but its use in straight vessels makes it more suitable. The guidewire requires a certain degree of stiffness to support the IVUS catheter.

The authors have performed five cases using this procedure with a success rate of 80% and no significant morbidity or mortality. With careful patient selection, IVUS-guided BPA can serve as an alternative treatment of choice in approaching lesions with CTO in patients with CTEPH.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Preceding IVUS into the CTO lesion.

Moving image 2. IVUS image during the procedure.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Preceding IVUS into the CTO lesion.

Moving image 2. IVUS image during the procedure.

Volume 14 Number 2
Jun 20, 2018
Volume 14 Number 2
View full issue


Key metrics

On the same subject

Image – Interventional flashlight

10.4244/EIJ-D-18-01212 Oct 4, 2019
Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension
Räber L et al
free

Image – Interventional flashlight

10.4244/EIJ-D-20-00652 Jun 11, 2021
A multistage strategy of perfusion SPECT and CT pulmonary angiogram in balloon pulmonary angioplasty for totally occluded lesions
Hosokawa K et al
free

10.4244/EIJV12SXA8 May 16, 2016
Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH)
Muller DW and Liebetrau C
free

Clinical research

10.4244/EIJ-D-20-01169 Oct 1, 2021
Outcomes of retrograde approach for chronic total occlusions by guidewire location
Fan Y et al
free
Trending articles
338.03

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
284.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved